| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melanoma | 63 | 2022 | 5511 | 3.190 |
Why?
|
| Facial Transplantation | 12 | 2023 | 226 | 2.830 |
Why?
|
| Skin | 97 | 2022 | 4372 | 2.820 |
Why?
|
| Graft vs Host Disease | 56 | 2020 | 2958 | 2.620 |
Why?
|
| Skin Neoplasms | 63 | 2024 | 5692 | 2.470 |
Why?
|
| Langerhans Cells | 28 | 2006 | 173 | 1.600 |
Why?
|
| Mast Cells | 30 | 2014 | 1544 | 1.590 |
Why?
|
| Nevus, Pigmented | 8 | 2017 | 219 | 1.320 |
Why?
|
| Graft Rejection | 18 | 2024 | 4397 | 1.190 |
Why?
|
| 5-Methylcytosine | 12 | 2019 | 154 | 1.110 |
Why?
|
| Neoplastic Stem Cells | 10 | 2014 | 1376 | 1.070 |
Why?
|
| SOXB1 Transcription Factors | 3 | 2011 | 284 | 1.020 |
Why?
|
| Skin Aging | 3 | 2020 | 127 | 0.970 |
Why?
|
| Dendritic Cells | 20 | 2018 | 2725 | 0.920 |
Why?
|
| Keratin-15 | 5 | 2019 | 22 | 0.900 |
Why?
|
| Melanocytes | 8 | 2012 | 515 | 0.880 |
Why?
|
| Epidermis | 20 | 2016 | 528 | 0.870 |
Why?
|
| Granuloma | 5 | 2015 | 319 | 0.860 |
Why?
|
| T-Lymphocytes | 42 | 2020 | 10183 | 0.830 |
Why?
|
| Hair Follicle | 5 | 2019 | 208 | 0.790 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2020 | 54 | 0.740 |
Why?
|
| Stem Cells | 16 | 2022 | 3567 | 0.730 |
Why?
|
| Carcinoma, Merkel Cell | 4 | 2024 | 303 | 0.710 |
Why?
|
| Apoptosis | 18 | 2020 | 9724 | 0.710 |
Why?
|
| Immunohistochemistry | 42 | 2018 | 11366 | 0.710 |
Why?
|
| Graft vs Host Reaction | 5 | 2017 | 104 | 0.700 |
Why?
|
| Epigenesis, Genetic | 10 | 2023 | 3646 | 0.690 |
Why?
|
| Dermatitis | 8 | 2016 | 199 | 0.690 |
Why?
|
| Mice, SCID | 22 | 2016 | 2716 | 0.660 |
Why?
|
| Skin Transplantation | 17 | 2022 | 1074 | 0.660 |
Why?
|
| Acantholysis | 2 | 2014 | 11 | 0.660 |
Why?
|
| Nodal Protein | 3 | 2016 | 37 | 0.650 |
Why?
|
| Bone Marrow Transplantation | 28 | 2013 | 2765 | 0.640 |
Why?
|
| Neovascularization, Pathologic | 9 | 2022 | 2638 | 0.630 |
Why?
|
| Keratinocytes | 12 | 2019 | 799 | 0.620 |
Why?
|
| Hypersensitivity, Delayed | 9 | 2010 | 484 | 0.620 |
Why?
|
| Mice | 123 | 2023 | 81201 | 0.620 |
Why?
|
| Skin Diseases | 12 | 2021 | 1066 | 0.610 |
Why?
|
| Wound Healing | 12 | 2022 | 2785 | 0.610 |
Why?
|
| Animals | 161 | 2023 | 168768 | 0.590 |
Why?
|
| Ultraviolet Rays | 6 | 2016 | 1060 | 0.580 |
Why?
|
| CD4-Positive T-Lymphocytes | 19 | 2018 | 4386 | 0.580 |
Why?
|
| Cell Degranulation | 13 | 2014 | 287 | 0.570 |
Why?
|
| Alopecia | 3 | 2014 | 382 | 0.570 |
Why?
|
| Matrix Metalloproteinase 3 | 2 | 2018 | 134 | 0.560 |
Why?
|
| Microscopy, Electron | 41 | 2014 | 2646 | 0.550 |
Why?
|
| Cytosine | 5 | 2015 | 216 | 0.550 |
Why?
|
| Cell Adhesion Molecules | 13 | 1996 | 1602 | 0.530 |
Why?
|
| Matrix Metalloproteinases | 2 | 2014 | 391 | 0.520 |
Why?
|
| Ichthyosis | 2 | 2015 | 60 | 0.520 |
Why?
|
| Graft vs Tumor Effect | 6 | 2017 | 72 | 0.510 |
Why?
|
| Laminin | 3 | 2014 | 419 | 0.510 |
Why?
|
| Disease Models, Animal | 31 | 2019 | 18034 | 0.490 |
Why?
|
| Scalp | 2 | 2014 | 380 | 0.470 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2014 | 109 | 0.460 |
Why?
|
| Antibodies, Monoclonal | 34 | 2018 | 9274 | 0.460 |
Why?
|
| Lymph Nodes | 11 | 2024 | 3476 | 0.450 |
Why?
|
| Mesenchymal Stem Cells | 4 | 2022 | 1632 | 0.440 |
Why?
|
| Humans | 265 | 2024 | 744366 | 0.440 |
Why?
|
| Intermediate Filament Proteins | 2 | 2011 | 269 | 0.440 |
Why?
|
| Lipocalins | 1 | 2014 | 170 | 0.440 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2013 | 79 | 0.430 |
Why?
|
| Mice, Inbred NOD | 14 | 2023 | 1879 | 0.430 |
Why?
|
| Epithelial Cells | 9 | 2022 | 3690 | 0.430 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2014 | 270 | 0.420 |
Why?
|
| Dioxygenases | 6 | 2019 | 316 | 0.420 |
Why?
|
| Psoriasis | 1 | 2019 | 902 | 0.400 |
Why?
|
| Lymphocyte Activation | 21 | 2018 | 5524 | 0.400 |
Why?
|
| Transplantation, Homologous | 19 | 2023 | 4777 | 0.390 |
Why?
|
| DNA Methylation | 9 | 2023 | 4285 | 0.380 |
Why?
|
| Tumor Necrosis Factor-alpha | 17 | 2020 | 4424 | 0.380 |
Why?
|
| Neoplasm Transplantation | 10 | 2018 | 2086 | 0.380 |
Why?
|
| Keratins | 6 | 2003 | 515 | 0.380 |
Why?
|
| Minor Histocompatibility Antigens | 8 | 2007 | 298 | 0.370 |
Why?
|
| Fluorescent Antibody Technique | 14 | 2017 | 2505 | 0.370 |
Why?
|
| Parabiosis | 1 | 2010 | 65 | 0.370 |
Why?
|
| Vaccinia virus | 4 | 2017 | 349 | 0.370 |
Why?
|
| Mice, Inbred BALB C | 25 | 2018 | 6386 | 0.360 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2016 | 2043 | 0.360 |
Why?
|
| Cell Transformation, Neoplastic | 8 | 2022 | 2943 | 0.360 |
Why?
|
| Merkel Cells | 1 | 2009 | 26 | 0.360 |
Why?
|
| CD8-Positive T-Lymphocytes | 15 | 2022 | 4479 | 0.350 |
Why?
|
| Galectin 1 | 3 | 2017 | 131 | 0.350 |
Why?
|
| Cell Line, Tumor | 20 | 2020 | 16690 | 0.350 |
Why?
|
| Transglutaminases | 5 | 1999 | 194 | 0.340 |
Why?
|
| Dysplastic Nevus Syndrome | 4 | 2000 | 63 | 0.340 |
Why?
|
| Neoplasm Proteins | 7 | 2020 | 3707 | 0.340 |
Why?
|
| Cytoplasmic Granules | 9 | 1998 | 610 | 0.340 |
Why?
|
| Carcinoma, Basal Cell | 5 | 2012 | 545 | 0.340 |
Why?
|
| DNA-Binding Proteins | 9 | 2019 | 9647 | 0.340 |
Why?
|
| Neoplasm Invasiveness | 8 | 2018 | 3616 | 0.330 |
Why?
|
| Antigens, Neoplasm | 9 | 2018 | 1988 | 0.330 |
Why?
|
| Cell Movement | 22 | 2018 | 5218 | 0.320 |
Why?
|
| Cell Proliferation | 20 | 2019 | 10483 | 0.320 |
Why?
|
| Nevus | 4 | 2014 | 204 | 0.320 |
Why?
|
| Dermis | 4 | 2022 | 207 | 0.320 |
Why?
|
| Sweat Gland Neoplasms | 2 | 2004 | 108 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 40 | 2022 | 21833 | 0.320 |
Why?
|
| Lactic Acid | 1 | 2013 | 1132 | 0.310 |
Why?
|
| Pathology, Clinical | 2 | 2021 | 368 | 0.310 |
Why?
|
| Collagen | 7 | 2014 | 2688 | 0.300 |
Why?
|
| Tumor Microenvironment | 3 | 2016 | 3590 | 0.300 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 2 | 2016 | 252 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2018 | 8432 | 0.300 |
Why?
|
| Transplantation, Heterologous | 8 | 2014 | 2383 | 0.300 |
Why?
|
| Lymphatic Metastasis | 7 | 2018 | 2924 | 0.300 |
Why?
|
| Chimera | 4 | 2017 | 485 | 0.300 |
Why?
|
| Mice, Knockout | 23 | 2018 | 14561 | 0.300 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 6 | 2021 | 1038 | 0.290 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 1939 | 0.290 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 6 | 2007 | 805 | 0.290 |
Why?
|
| Limbus Corneae | 2 | 2022 | 144 | 0.290 |
Why?
|
| Immunoenzyme Techniques | 23 | 2017 | 1799 | 0.290 |
Why?
|
| Organ Culture Techniques | 9 | 2012 | 813 | 0.290 |
Why?
|
| Growth Inhibitors | 1 | 2008 | 385 | 0.290 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2018 | 713 | 0.290 |
Why?
|
| Chymases | 6 | 2014 | 99 | 0.280 |
Why?
|
| Antigens, CD | 10 | 2018 | 4026 | 0.280 |
Why?
|
| Transforming Growth Factor beta | 4 | 2014 | 2007 | 0.280 |
Why?
|
| Melanoma, Experimental | 3 | 2020 | 561 | 0.270 |
Why?
|
| Antigens, CD1 | 3 | 1998 | 437 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2022 | 4554 | 0.270 |
Why?
|
| Interferon-gamma | 10 | 2016 | 3207 | 0.270 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2008 | 838 | 0.270 |
Why?
|
| Dermatitis, Atopic | 4 | 2009 | 654 | 0.270 |
Why?
|
| HLA-DR Antigens | 10 | 1998 | 645 | 0.260 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2022 | 496 | 0.260 |
Why?
|
| Stem Cell Transplantation | 4 | 2014 | 1620 | 0.260 |
Why?
|
| Antigens | 6 | 2016 | 1466 | 0.260 |
Why?
|
| Immune Tolerance | 5 | 2023 | 2259 | 0.250 |
Why?
|
| Serine Endopeptidases | 6 | 2014 | 1073 | 0.250 |
Why?
|
| Graft Survival | 7 | 2024 | 3737 | 0.250 |
Why?
|
| Imidazoles | 4 | 2016 | 1206 | 0.250 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2021 | 1115 | 0.250 |
Why?
|
| Interleukins | 3 | 2016 | 791 | 0.250 |
Why?
|
| Female | 102 | 2024 | 380193 | 0.250 |
Why?
|
| T-Lymphocytes, Regulatory | 7 | 2023 | 2988 | 0.250 |
Why?
|
| Placenta | 1 | 2014 | 1699 | 0.250 |
Why?
|
| Neovascularization, Physiologic | 3 | 2022 | 1351 | 0.250 |
Why?
|
| Vaccinia | 2 | 2017 | 76 | 0.240 |
Why?
|
| Facial Dermatoses | 2 | 2015 | 87 | 0.240 |
Why?
|
| Cytokines | 10 | 2022 | 7323 | 0.240 |
Why?
|
| Uterine Neoplasms | 1 | 2014 | 1513 | 0.240 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 3 | 2016 | 207 | 0.240 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 11 | 2018 | 5445 | 0.240 |
Why?
|
| Scrotum | 1 | 2004 | 115 | 0.240 |
Why?
|
| Male | 114 | 2021 | 350115 | 0.240 |
Why?
|
| Carcinosarcoma | 1 | 2004 | 108 | 0.240 |
Why?
|
| Mastocytosis | 3 | 1997 | 160 | 0.240 |
Why?
|
| Drug Eruptions | 4 | 2015 | 297 | 0.240 |
Why?
|
| Blotting, Western | 8 | 2016 | 5181 | 0.230 |
Why?
|
| Oximes | 3 | 2016 | 311 | 0.230 |
Why?
|
| N-Acetylglucosaminyltransferases | 2 | 2022 | 171 | 0.230 |
Why?
|
| Facial Injuries | 2 | 2015 | 183 | 0.230 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2003 | 707 | 0.230 |
Why?
|
| Biopsy | 15 | 2020 | 6755 | 0.230 |
Why?
|
| Mice, Inbred Strains | 13 | 2011 | 1828 | 0.220 |
Why?
|
| E-Selectin | 9 | 2008 | 579 | 0.220 |
Why?
|
| Mice, Inbred DBA | 8 | 2011 | 642 | 0.220 |
Why?
|
| Carrier Proteins | 5 | 2014 | 5023 | 0.220 |
Why?
|
| Antigens, Surface | 9 | 1994 | 1663 | 0.220 |
Why?
|
| Graft vs Leukemia Effect | 4 | 2011 | 111 | 0.220 |
Why?
|
| Dermatology | 3 | 2015 | 872 | 0.210 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 2850 | 0.210 |
Why?
|
| Immunosuppressive Agents | 7 | 2022 | 4153 | 0.210 |
Why?
|
| Hydrostatic Pressure | 2 | 2014 | 106 | 0.210 |
Why?
|
| Negative-Pressure Wound Therapy | 3 | 2014 | 150 | 0.210 |
Why?
|
| Precancerous Conditions | 4 | 2017 | 975 | 0.200 |
Why?
|
| Neoplasms, Experimental | 3 | 2018 | 1276 | 0.200 |
Why?
|
| Immunologic Techniques | 5 | 1996 | 219 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 4751 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2020 | 5172 | 0.200 |
Why?
|
| Dermatitis, Contact | 3 | 2003 | 129 | 0.200 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 1 | 2022 | 68 | 0.200 |
Why?
|
| Nuclear Proteins | 4 | 2014 | 5856 | 0.200 |
Why?
|
| Mice, Nude | 6 | 2020 | 3689 | 0.200 |
Why?
|
| Middle Aged | 52 | 2021 | 213390 | 0.200 |
Why?
|
| Mucous Membrane | 3 | 2020 | 673 | 0.200 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 6 | 2006 | 906 | 0.190 |
Why?
|
| Carcinoma, Squamous Cell | 7 | 2017 | 4034 | 0.190 |
Why?
|
| Antibodies, Neoplasm | 2 | 2020 | 286 | 0.190 |
Why?
|
| Oncogene Protein v-akt | 1 | 2020 | 135 | 0.190 |
Why?
|
| Interleukin-2 | 5 | 2023 | 1904 | 0.190 |
Why?
|
| Sarcoma, Kaposi | 1 | 2003 | 370 | 0.190 |
Why?
|
| Regeneration | 4 | 2014 | 1485 | 0.180 |
Why?
|
| Interleukin-23 | 3 | 2016 | 194 | 0.180 |
Why?
|
| Fibroblasts | 6 | 2019 | 4162 | 0.180 |
Why?
|
| Nasal Mucosa | 2 | 2020 | 373 | 0.180 |
Why?
|
| Neoplasms | 9 | 2022 | 21696 | 0.180 |
Why?
|
| Cells, Cultured | 19 | 2022 | 19233 | 0.180 |
Why?
|
| Membrane Glycoproteins | 8 | 2010 | 3771 | 0.180 |
Why?
|
| Flow Cytometry | 12 | 2017 | 5974 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2010 | 3390 | 0.180 |
Why?
|
| Galectins | 1 | 2022 | 268 | 0.180 |
Why?
|
| Chemokines | 3 | 2022 | 970 | 0.180 |
Why?
|
| In Situ Hybridization | 2 | 2014 | 1950 | 0.170 |
Why?
|
| Epithelium, Corneal | 1 | 2022 | 247 | 0.170 |
Why?
|
| Transplantation Chimera | 4 | 2006 | 613 | 0.170 |
Why?
|
| Interleukin-17 | 3 | 2020 | 901 | 0.170 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 2 | 1999 | 307 | 0.170 |
Why?
|
| Urocanic Acid | 1 | 1999 | 2 | 0.170 |
Why?
|
| Hair | 3 | 1997 | 481 | 0.170 |
Why?
|
| Melanoma-Specific Antigens | 3 | 2018 | 80 | 0.170 |
Why?
|
| Mouth Mucosa | 2 | 2020 | 434 | 0.170 |
Why?
|
| Adult | 62 | 2021 | 214052 | 0.170 |
Why?
|
| Endothelium | 6 | 1993 | 778 | 0.170 |
Why?
|
| N-Acetylhexosaminyltransferases | 1 | 2018 | 5 | 0.170 |
Why?
|
| Histocytochemistry | 10 | 1997 | 719 | 0.170 |
Why?
|
| Cyclosporins | 3 | 1987 | 220 | 0.170 |
Why?
|
| Histone Code | 1 | 2019 | 163 | 0.160 |
Why?
|
| Diabetic Foot | 1 | 2022 | 355 | 0.160 |
Why?
|
| Histocompatibility Antigens Class II | 10 | 1987 | 1475 | 0.160 |
Why?
|
| Minor Histocompatibility Loci | 3 | 1986 | 18 | 0.160 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1999 | 293 | 0.160 |
Why?
|
| Lymphoma, T-Cell | 2 | 2012 | 299 | 0.160 |
Why?
|
| Mixed Function Oxygenases | 1 | 2019 | 272 | 0.160 |
Why?
|
| Lip Neoplasms | 1 | 2018 | 37 | 0.160 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2019 | 182 | 0.160 |
Why?
|
| Cartilage | 2 | 2014 | 818 | 0.160 |
Why?
|
| Dermatitis, Phototoxic | 1 | 1998 | 15 | 0.160 |
Why?
|
| Gene Expression Profiling | 9 | 2018 | 9445 | 0.160 |
Why?
|
| Neoplasm Staging | 6 | 2015 | 11031 | 0.160 |
Why?
|
| Mouth Diseases | 3 | 2018 | 241 | 0.160 |
Why?
|
| Keratolytic Agents | 1 | 1998 | 31 | 0.160 |
Why?
|
| Adenylate Kinase | 1 | 2018 | 99 | 0.160 |
Why?
|
| Integrins | 5 | 2011 | 846 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4463 | 0.160 |
Why?
|
| Cat Diseases | 1 | 1997 | 37 | 0.150 |
Why?
|
| Skin Physiological Phenomena | 4 | 1999 | 180 | 0.150 |
Why?
|
| Up-Regulation | 10 | 2018 | 4222 | 0.150 |
Why?
|
| T-Lymphocytes, Cytotoxic | 6 | 2011 | 1821 | 0.150 |
Why?
|
| Receptors, Cell Surface | 4 | 2012 | 2865 | 0.150 |
Why?
|
| Lasers | 4 | 1987 | 952 | 0.150 |
Why?
|
| Mice, Inbred CBA | 5 | 1998 | 448 | 0.150 |
Why?
|
| Phosphorylation | 3 | 2020 | 8436 | 0.150 |
Why?
|
| Collagen Type I | 2 | 2011 | 592 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 5534 | 0.150 |
Why?
|
| Orbit | 1 | 2000 | 426 | 0.150 |
Why?
|
| Pemphigus, Benign Familial | 1 | 1997 | 8 | 0.150 |
Why?
|
| Endothelium, Vascular | 11 | 2010 | 4459 | 0.150 |
Why?
|
| Aging | 4 | 2023 | 8664 | 0.150 |
Why?
|
| Immunoglobulin E | 4 | 2009 | 1463 | 0.150 |
Why?
|
| Molecular Targeted Therapy | 5 | 2016 | 2725 | 0.150 |
Why?
|
| Aged | 41 | 2021 | 163288 | 0.150 |
Why?
|
| RNA, Messenger | 11 | 2022 | 13035 | 0.150 |
Why?
|
| Acute Disease | 11 | 2018 | 7147 | 0.150 |
Why?
|
| Spleen | 7 | 2018 | 2362 | 0.150 |
Why?
|
| Tumor Escape | 2 | 2011 | 350 | 0.150 |
Why?
|
| Skin Diseases, Infectious | 1 | 2017 | 74 | 0.140 |
Why?
|
| Dermatomyositis | 1 | 2019 | 224 | 0.140 |
Why?
|
| Extracellular Matrix | 4 | 2018 | 1741 | 0.140 |
Why?
|
| Tissue Donors | 4 | 2014 | 2241 | 0.140 |
Why?
|
| Genes, MHC Class II | 1 | 1997 | 457 | 0.140 |
Why?
|
| Substance P | 3 | 1998 | 335 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2020 | 3554 | 0.140 |
Why?
|
| Face | 2 | 2020 | 994 | 0.140 |
Why?
|
| Etoposide | 2 | 2016 | 641 | 0.140 |
Why?
|
| Glycosaminoglycans | 2 | 1990 | 624 | 0.140 |
Why?
|
| Cell Hypoxia | 1 | 2019 | 675 | 0.140 |
Why?
|
| Dog Diseases | 1 | 1997 | 138 | 0.140 |
Why?
|
| Interleukin-1 | 3 | 2012 | 1263 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2023 | 2540 | 0.130 |
Why?
|
| Folliculitis | 2 | 2015 | 28 | 0.130 |
Why?
|
| Receptors, IgE | 1 | 1997 | 389 | 0.130 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 379 | 0.130 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 297 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2014 | 1677 | 0.130 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 651 | 0.130 |
Why?
|
| Hemangioma | 1 | 2000 | 738 | 0.130 |
Why?
|
| Cell Polarity | 2 | 2016 | 645 | 0.130 |
Why?
|
| Aged, 80 and over | 16 | 2021 | 57776 | 0.130 |
Why?
|
| Basement Membrane | 6 | 1993 | 357 | 0.130 |
Why?
|
| Microscopy, Immunoelectron | 4 | 1998 | 319 | 0.130 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 834 | 0.130 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2016 | 215 | 0.130 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 1995 | 102 | 0.130 |
Why?
|
| Aristolochic Acids | 1 | 2014 | 8 | 0.130 |
Why?
|
| Port-Wine Stain | 1 | 2014 | 33 | 0.130 |
Why?
|
| Pyrrolizidine Alkaloids | 1 | 2014 | 10 | 0.130 |
Why?
|
| Oligopeptides | 2 | 1997 | 1189 | 0.130 |
Why?
|
| Lymphoid Tissue | 5 | 2011 | 455 | 0.130 |
Why?
|
| Indoles | 2 | 2014 | 1839 | 0.130 |
Why?
|
| Tretinoin | 1 | 1998 | 517 | 0.130 |
Why?
|
| Mice, Inbred C3H | 7 | 2015 | 964 | 0.120 |
Why?
|
| Carboplatin | 2 | 2016 | 801 | 0.120 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 3 | 2000 | 141 | 0.120 |
Why?
|
| Aminoquinolines | 3 | 2009 | 109 | 0.120 |
Why?
|
| Ultraviolet Therapy | 1 | 2014 | 81 | 0.120 |
Why?
|
| Kaposi Varicelliform Eruption | 2 | 2017 | 47 | 0.120 |
Why?
|
| Cellulitis | 1 | 2016 | 206 | 0.120 |
Why?
|
| Phenotype | 14 | 2022 | 16367 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2014 | 71 | 0.120 |
Why?
|
| Histocompatibility Testing | 1 | 2016 | 741 | 0.120 |
Why?
|
| Tacrolimus | 1 | 2018 | 743 | 0.120 |
Why?
|
| Facial Neoplasms | 1 | 2015 | 121 | 0.120 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2014 | 100 | 0.120 |
Why?
|
| RNA, Small Interfering | 3 | 2020 | 3505 | 0.120 |
Why?
|
| Trophoblastic Neoplasms | 1 | 2014 | 87 | 0.120 |
Why?
|
| Intestine, Small | 5 | 2012 | 1240 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2018 | 693 | 0.120 |
Why?
|
| Vitiligo | 1 | 2014 | 89 | 0.120 |
Why?
|
| Models, Biological | 6 | 2020 | 9584 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2017 | 11525 | 0.120 |
Why?
|
| Chickenpox | 1 | 2014 | 131 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 7 | 2018 | 6313 | 0.120 |
Why?
|
| Keratin-14 | 2 | 2010 | 57 | 0.120 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 2 | 2013 | 197 | 0.120 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2017 | 450 | 0.120 |
Why?
|
| Down-Regulation | 2 | 2019 | 3001 | 0.120 |
Why?
|
| Immunization | 2 | 2016 | 1256 | 0.120 |
Why?
|
| Sulfonamides | 2 | 2014 | 1940 | 0.120 |
Why?
|
| Mutation | 4 | 2016 | 29786 | 0.120 |
Why?
|
| Pyridazines | 1 | 2015 | 202 | 0.120 |
Why?
|
| Gene Expression | 6 | 2019 | 7798 | 0.110 |
Why?
|
| Carcinoid Tumor | 1 | 2015 | 235 | 0.110 |
Why?
|
| Fluorouracil | 2 | 2011 | 1619 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 1525 | 0.110 |
Why?
|
| Sentinel Lymph Node Biopsy | 5 | 2014 | 710 | 0.110 |
Why?
|
| Choriocarcinoma | 1 | 2014 | 126 | 0.110 |
Why?
|
| Gels | 1 | 2014 | 427 | 0.110 |
Why?
|
| Carcinoma, Small Cell | 1 | 2015 | 420 | 0.110 |
Why?
|
| Epidermolysis Bullosa Simplex | 1 | 1992 | 13 | 0.110 |
Why?
|
| Autoimmunity | 2 | 2022 | 1350 | 0.110 |
Why?
|
| Connective Tissue | 2 | 1995 | 420 | 0.110 |
Why?
|
| Exons | 1 | 2019 | 2439 | 0.110 |
Why?
|
| Th1 Cells | 2 | 2016 | 1057 | 0.110 |
Why?
|
| Protein Precursors | 3 | 1987 | 1154 | 0.110 |
Why?
|
| Desmosomes | 1 | 1992 | 73 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 1997 | 776 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 565 | 0.110 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 2 | 1993 | 294 | 0.110 |
Why?
|
| Antineoplastic Agents | 8 | 2016 | 13693 | 0.110 |
Why?
|
| Lymphoma | 4 | 2017 | 1877 | 0.110 |
Why?
|
| Actins | 2 | 2011 | 2121 | 0.110 |
Why?
|
| Chondrogenesis | 1 | 2014 | 247 | 0.110 |
Why?
|
| Adenofibroma | 1 | 1992 | 25 | 0.110 |
Why?
|
| Signal Transduction | 7 | 2021 | 23404 | 0.110 |
Why?
|
| Retroviridae Infections | 3 | 1988 | 151 | 0.110 |
Why?
|
| Leukotriene B4 | 2 | 2012 | 294 | 0.110 |
Why?
|
| Adenoma, Sweat Gland | 1 | 1992 | 18 | 0.110 |
Why?
|
| Gene Expression Regulation | 9 | 2014 | 12073 | 0.110 |
Why?
|
| Terminology as Topic | 2 | 1998 | 1547 | 0.110 |
Why?
|
| Epithelium | 8 | 2011 | 1679 | 0.110 |
Why?
|
| Integrin beta Chains | 2 | 2018 | 121 | 0.110 |
Why?
|
| Transfection | 3 | 2018 | 5895 | 0.110 |
Why?
|
| Neoplasm Metastasis | 5 | 2016 | 4851 | 0.110 |
Why?
|
| Dexamethasone | 2 | 2018 | 1951 | 0.110 |
Why?
|
| Trophoblasts | 1 | 2014 | 215 | 0.110 |
Why?
|
| Mouth Neoplasms | 2 | 2017 | 601 | 0.100 |
Why?
|
| Panniculitis | 1 | 2012 | 45 | 0.100 |
Why?
|
| Intermediate Filaments | 1 | 1992 | 175 | 0.100 |
Why?
|
| S100 Proteins | 2 | 2004 | 259 | 0.100 |
Why?
|
| Carcinoembryonic Antigen | 2 | 2011 | 349 | 0.100 |
Why?
|
| HLA-D Antigens | 2 | 1992 | 134 | 0.100 |
Why?
|
| Carcinogens | 1 | 2014 | 466 | 0.100 |
Why?
|
| Amino Sugars | 1 | 2011 | 40 | 0.100 |
Why?
|
| Cell Differentiation | 7 | 2022 | 11486 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2022 | 3511 | 0.100 |
Why?
|
| Fetal Proteins | 1 | 2012 | 94 | 0.100 |
Why?
|
| Ligands | 6 | 2022 | 3282 | 0.100 |
Why?
|
| Dacarbazine | 1 | 2015 | 566 | 0.100 |
Why?
|
| Antigens, Differentiation | 2 | 2012 | 927 | 0.100 |
Why?
|
| Subcutaneous Tissue | 1 | 2012 | 135 | 0.100 |
Why?
|
| Cell Communication | 3 | 2016 | 1621 | 0.100 |
Why?
|
| Cell Adhesion | 7 | 1997 | 3144 | 0.100 |
Why?
|
| Leukocytes | 4 | 1995 | 2045 | 0.100 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2011 | 61 | 0.100 |
Why?
|
| Polysaccharides | 1 | 2018 | 1059 | 0.100 |
Why?
|
| Tight Junctions | 1 | 2014 | 311 | 0.100 |
Why?
|
| Venules | 2 | 1991 | 165 | 0.100 |
Why?
|
| Hydatidiform Mole | 1 | 2014 | 279 | 0.100 |
Why?
|
| Erdheim-Chester Disease | 1 | 2010 | 11 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2015 | 692 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 560 | 0.100 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2011 | 135 | 0.100 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 264 | 0.100 |
Why?
|
| Histiocytosis | 1 | 1990 | 40 | 0.090 |
Why?
|
| Diagnosis, Differential | 9 | 2014 | 12961 | 0.090 |
Why?
|
| Hemostasis | 1 | 1993 | 458 | 0.090 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2011 | 75 | 0.090 |
Why?
|
| Major Histocompatibility Complex | 4 | 2006 | 936 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2014 | 624 | 0.090 |
Why?
|
| Lymphocyte Transfusion | 3 | 2004 | 236 | 0.090 |
Why?
|
| Cadherins | 2 | 2010 | 907 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 504 | 0.090 |
Why?
|
| Immunologic Memory | 3 | 2014 | 1348 | 0.090 |
Why?
|
| Lichen Planus | 4 | 1997 | 57 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 1988 | 2232 | 0.090 |
Why?
|
| Epigenomics | 1 | 2015 | 903 | 0.090 |
Why?
|
| Neutrophil Infiltration | 1 | 2012 | 391 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 1788 | 0.090 |
Why?
|
| Uveitis | 1 | 1993 | 375 | 0.090 |
Why?
|
| Receptors, Interleukin-2 | 3 | 2018 | 573 | 0.090 |
Why?
|
| Stochastic Processes | 1 | 2011 | 344 | 0.090 |
Why?
|
| Wounds and Injuries | 2 | 2014 | 2400 | 0.090 |
Why?
|
| Histocompatibility Antigens | 1 | 1991 | 471 | 0.090 |
Why?
|
| Proteomics | 1 | 2023 | 3638 | 0.090 |
Why?
|
| Random Allocation | 1 | 2014 | 2428 | 0.090 |
Why?
|
| Cell Cycle Proteins | 2 | 2018 | 3464 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2018 | 2926 | 0.090 |
Why?
|
| Axons | 1 | 1998 | 1685 | 0.090 |
Why?
|
| Airway Obstruction | 1 | 2014 | 664 | 0.090 |
Why?
|
| Cystatin C | 1 | 2010 | 250 | 0.090 |
Why?
|
| Granuloma Annulare | 1 | 2009 | 28 | 0.090 |
Why?
|
| Hematopoietic System | 1 | 2009 | 109 | 0.090 |
Why?
|
| Lung | 3 | 2020 | 9857 | 0.090 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2009 | 87 | 0.090 |
Why?
|
| Cell Transdifferentiation | 1 | 2010 | 172 | 0.090 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2009 | 91 | 0.080 |
Why?
|
| Histiocytosis, Langerhans-Cell | 4 | 1985 | 171 | 0.080 |
Why?
|
| Calcitonin Gene-Related Peptide | 3 | 1998 | 306 | 0.080 |
Why?
|
| Interleukin-10 | 4 | 2011 | 1200 | 0.080 |
Why?
|
| Immunotherapy | 5 | 2018 | 4446 | 0.080 |
Why?
|
| Fas Ligand Protein | 2 | 2007 | 216 | 0.080 |
Why?
|
| Tongue | 1 | 2012 | 406 | 0.080 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2010 | 362 | 0.080 |
Why?
|
| Macrophages | 7 | 2018 | 5660 | 0.080 |
Why?
|
| Swine, Miniature | 1 | 1991 | 961 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 727 | 0.080 |
Why?
|
| Cytotoxicity, Immunologic | 6 | 2013 | 1369 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3338 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2108 | 0.080 |
Why?
|
| Microcirculation | 5 | 1995 | 1287 | 0.080 |
Why?
|
| Transplantation Immunology | 2 | 2011 | 546 | 0.080 |
Why?
|
| Cell Lineage | 3 | 2008 | 2504 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2887 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4805 | 0.080 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2014 | 685 | 0.080 |
Why?
|
| Cell Count | 3 | 2014 | 1856 | 0.080 |
Why?
|
| MART-1 Antigen | 1 | 2008 | 64 | 0.080 |
Why?
|
| Ceramides | 1 | 2009 | 199 | 0.080 |
Why?
|
| Blood Vessels | 3 | 1993 | 1125 | 0.080 |
Why?
|
| Small Molecule Libraries | 1 | 2014 | 720 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2008 | 112 | 0.080 |
Why?
|
| Interleukin-1alpha | 1 | 2008 | 85 | 0.080 |
Why?
|
| Oxides | 2 | 2011 | 405 | 0.080 |
Why?
|
| Edema | 1 | 2012 | 789 | 0.080 |
Why?
|
| Antigens, CD34 | 2 | 2000 | 659 | 0.080 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 1988 | 40 | 0.080 |
Why?
|
| Mice, Transgenic | 5 | 2018 | 9735 | 0.080 |
Why?
|
| Arthritis | 1 | 1993 | 661 | 0.080 |
Why?
|
| Ferric Compounds | 2 | 2011 | 374 | 0.080 |
Why?
|
| Receptors, Immunologic | 2 | 2012 | 1423 | 0.080 |
Why?
|
| Disease Progression | 6 | 2017 | 13286 | 0.080 |
Why?
|
| Receptors, Chemokine | 3 | 2006 | 670 | 0.080 |
Why?
|
| P-Selectin | 1 | 2010 | 601 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2021 | 3326 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3508 | 0.080 |
Why?
|
| Drug Hypersensitivity | 1 | 2016 | 884 | 0.080 |
Why?
|
| Adoptive Transfer | 3 | 2017 | 844 | 0.080 |
Why?
|
| Cell Line | 4 | 2014 | 16000 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 552 | 0.080 |
Why?
|
| Epitopes | 2 | 2011 | 2571 | 0.080 |
Why?
|
| HLA-DQ Antigens | 1 | 1988 | 210 | 0.080 |
Why?
|
| Granulation Tissue | 3 | 2011 | 93 | 0.070 |
Why?
|
| Autocrine Communication | 1 | 2008 | 171 | 0.070 |
Why?
|
| Immunoglobulin G | 5 | 2012 | 4561 | 0.070 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2011 | 640 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2015 | 1158 | 0.070 |
Why?
|
| Survival Rate | 8 | 2021 | 12788 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2010 | 1837 | 0.070 |
Why?
|
| Clone Cells | 2 | 2003 | 1692 | 0.070 |
Why?
|
| Infant, Newborn | 11 | 2000 | 25628 | 0.070 |
Why?
|
| Hyperplasia | 5 | 2010 | 1185 | 0.070 |
Why?
|
| Sunlight | 1 | 2009 | 325 | 0.070 |
Why?
|
| Prognosis | 10 | 2021 | 29060 | 0.070 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2015 | 990 | 0.070 |
Why?
|
| Quality Control | 2 | 2020 | 841 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 5 | 2008 | 6171 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 4 | 1997 | 1159 | 0.070 |
Why?
|
| Transgenes | 1 | 2010 | 1009 | 0.070 |
Why?
|
| Palatine Tonsil | 1 | 1987 | 193 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 1865 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2018 | 9145 | 0.070 |
Why?
|
| Isoantigens | 2 | 2008 | 567 | 0.070 |
Why?
|
| Antigen-Presenting Cells | 4 | 2013 | 973 | 0.070 |
Why?
|
| Drug Interactions | 3 | 1999 | 1460 | 0.070 |
Why?
|
| Liver | 7 | 2014 | 7475 | 0.070 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2009 | 985 | 0.070 |
Why?
|
| Fever | 1 | 2014 | 1616 | 0.070 |
Why?
|
| Stem Cell Niche | 1 | 2009 | 346 | 0.070 |
Why?
|
| Myoblasts, Skeletal | 1 | 2006 | 76 | 0.070 |
Why?
|
| Mastocytoma | 1 | 2005 | 5 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 3 | 2023 | 1613 | 0.070 |
Why?
|
| Glucose | 1 | 2018 | 4398 | 0.070 |
Why?
|
| Transformation, Genetic | 1 | 1986 | 192 | 0.070 |
Why?
|
| Erythema Nodosum | 1 | 1986 | 30 | 0.070 |
Why?
|
| Administration, Topical | 2 | 2018 | 690 | 0.070 |
Why?
|
| Cell Division | 5 | 2009 | 4569 | 0.070 |
Why?
|
| Cell Survival | 3 | 2018 | 5882 | 0.070 |
Why?
|
| Stem Cell Factor | 2 | 1997 | 219 | 0.070 |
Why?
|
| Leprosy | 1 | 1986 | 124 | 0.070 |
Why?
|
| Apocrine Glands | 1 | 1985 | 31 | 0.070 |
Why?
|
| Killer Cells, Natural | 4 | 2003 | 2133 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2006 | 295 | 0.070 |
Why?
|
| Sweat Glands | 1 | 1985 | 31 | 0.060 |
Why?
|
| Immunomodulation | 2 | 2020 | 541 | 0.060 |
Why?
|
| Tissue Array Analysis | 3 | 2016 | 553 | 0.060 |
Why?
|
| Age Factors | 3 | 2020 | 18373 | 0.060 |
Why?
|
| Retroviridae | 1 | 1988 | 914 | 0.060 |
Why?
|
| Colorectal Neoplasms | 2 | 2018 | 6773 | 0.060 |
Why?
|
| Cell Membrane | 4 | 2009 | 3749 | 0.060 |
Why?
|
| Melanins | 1 | 1987 | 289 | 0.060 |
Why?
|
| Blotting, Southern | 2 | 2003 | 803 | 0.060 |
Why?
|
| Glycoproteins | 4 | 1987 | 2266 | 0.060 |
Why?
|
| Urticaria Pigmentosa | 2 | 1997 | 17 | 0.060 |
Why?
|
| Peptide Fragments | 3 | 2004 | 5096 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 913 | 0.060 |
Why?
|
| Paget Disease, Extramammary | 1 | 1985 | 45 | 0.060 |
Why?
|
| Epirubicin | 1 | 2004 | 80 | 0.060 |
Why?
|
| Tryptases | 2 | 1997 | 190 | 0.060 |
Why?
|
| Lymphocyte Count | 3 | 2012 | 793 | 0.060 |
Why?
|
| Retrospective Studies | 9 | 2024 | 77460 | 0.060 |
Why?
|
| Tissue Distribution | 2 | 2019 | 2327 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2020 | 3481 | 0.060 |
Why?
|
| Neutrophils | 7 | 2012 | 3721 | 0.060 |
Why?
|
| Lectins | 1 | 1987 | 513 | 0.060 |
Why?
|
| Pemphigus | 2 | 1997 | 105 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 2088 | 0.060 |
Why?
|
| Cell Separation | 2 | 2010 | 1751 | 0.060 |
Why?
|
| Ovarian Neoplasms | 2 | 2017 | 4839 | 0.060 |
Why?
|
| Eccrine Glands | 2 | 2003 | 45 | 0.060 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2004 | 71 | 0.060 |
Why?
|
| Th2 Cells | 2 | 2009 | 1061 | 0.060 |
Why?
|
| Factor XIIIa | 1 | 2003 | 10 | 0.060 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 2003 | 43 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 6539 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2008 | 1101 | 0.060 |
Why?
|
| Lingual Frenum | 1 | 2003 | 8 | 0.060 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 2 | 2016 | 88 | 0.060 |
Why?
|
| Lymphatic Vessels | 2 | 2005 | 353 | 0.060 |
Why?
|
| Mitomycin | 1 | 2004 | 259 | 0.060 |
Why?
|
| Lymphocytes | 5 | 1999 | 2617 | 0.060 |
Why?
|
| Perineum | 1 | 1985 | 211 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2010 | 1534 | 0.060 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 5749 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2008 | 8949 | 0.060 |
Why?
|
| Tissue Embedding | 1 | 2003 | 43 | 0.060 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2010 | 934 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 3 | 2015 | 1656 | 0.060 |
Why?
|
| Image Enhancement | 2 | 2005 | 2921 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 9240 | 0.060 |
Why?
|
| History, 20th Century | 2 | 2010 | 2740 | 0.060 |
Why?
|
| Telemedicine | 1 | 2021 | 2872 | 0.060 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 3 | 1996 | 41 | 0.060 |
Why?
|
| Histocompatibility | 1 | 2004 | 330 | 0.060 |
Why?
|
| Fetus | 2 | 2008 | 1880 | 0.060 |
Why?
|
| Recombinant Proteins | 3 | 1993 | 6621 | 0.060 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2006 | 555 | 0.060 |
Why?
|
| Monocytes | 5 | 2000 | 2596 | 0.060 |
Why?
|
| Immunity, Cellular | 5 | 2014 | 1607 | 0.060 |
Why?
|
| Veins | 1 | 1987 | 770 | 0.060 |
Why?
|
| Complementarity Determining Regions | 1 | 2003 | 149 | 0.060 |
Why?
|
| Apolipoproteins | 1 | 1985 | 317 | 0.050 |
Why?
|
| Lymphoma, B-Cell | 1 | 2009 | 931 | 0.050 |
Why?
|
| Swine | 5 | 2014 | 5918 | 0.050 |
Why?
|
| Nucleoproteins | 1 | 2023 | 115 | 0.050 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 1986 | 281 | 0.050 |
Why?
|
| Adipocytes | 1 | 2009 | 1185 | 0.050 |
Why?
|
| Tissue Scaffolds | 1 | 2009 | 956 | 0.050 |
Why?
|
| Sunburn | 1 | 2003 | 155 | 0.050 |
Why?
|
| Fibroma | 2 | 2017 | 212 | 0.050 |
Why?
|
| Immunity, Innate | 2 | 2012 | 2962 | 0.050 |
Why?
|
| Pyrimidinones | 2 | 2016 | 370 | 0.050 |
Why?
|
| Vincristine | 1 | 2004 | 1039 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2014 | 3280 | 0.050 |
Why?
|
| Recurrence | 3 | 2017 | 8340 | 0.050 |
Why?
|
| Anal Canal | 1 | 1985 | 376 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2016 | 1837 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 14723 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 644 | 0.050 |
Why?
|
| Transcription Factors | 4 | 2014 | 12207 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 1295 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2008 | 3712 | 0.050 |
Why?
|
| Cell Nucleus | 3 | 2008 | 2969 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 1985 | 634 | 0.050 |
Why?
|
| Lymphomatoid Granulomatosis | 1 | 1981 | 16 | 0.050 |
Why?
|
| Morphine | 3 | 1991 | 657 | 0.050 |
Why?
|
| Exanthema | 1 | 1987 | 501 | 0.050 |
Why?
|
| Inflammation | 6 | 2014 | 10637 | 0.050 |
Why?
|
| Immunochemistry | 3 | 1986 | 124 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2003 | 1101 | 0.050 |
Why?
|
| Capillaries | 3 | 1995 | 773 | 0.050 |
Why?
|
| Cathepsins | 2 | 2010 | 241 | 0.050 |
Why?
|
| Iron | 3 | 2011 | 1774 | 0.050 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 1997 | 547 | 0.050 |
Why?
|
| Liability, Legal | 1 | 2003 | 213 | 0.050 |
Why?
|
| Vasculitis | 1 | 1986 | 519 | 0.050 |
Why?
|
| Blister | 2 | 1999 | 86 | 0.050 |
Why?
|
| Thigh | 2 | 2015 | 247 | 0.050 |
Why?
|
| Neoplasms, Second Primary | 1 | 2009 | 1062 | 0.050 |
Why?
|
| Hematopoiesis | 2 | 2016 | 2073 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2016 | 7182 | 0.050 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2021 | 126 | 0.050 |
Why?
|
| Guinea Pigs | 4 | 1993 | 1386 | 0.050 |
Why?
|
| Organ Specificity | 3 | 2011 | 2008 | 0.050 |
Why?
|
| Immunoglobulins | 2 | 2022 | 881 | 0.050 |
Why?
|
| Chemokines, CC | 1 | 2022 | 291 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 2917 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2017 | 1683 | 0.050 |
Why?
|
| Immediate-Early Proteins | 2 | 2014 | 453 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2010 | 3617 | 0.050 |
Why?
|
| Calcimycin | 2 | 1991 | 222 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 3 | 2003 | 2700 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2012 | 3177 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 1678 | 0.050 |
Why?
|
| Factor XIII | 1 | 2000 | 59 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2018 | 2715 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5223 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2022 | 2455 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 2 | 2020 | 2166 | 0.050 |
Why?
|
| Young Adult | 6 | 2018 | 56429 | 0.050 |
Why?
|
| Cytoplasm | 3 | 1998 | 1536 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2003 | 589 | 0.050 |
Why?
|
| Immunity, Humoral | 2 | 2017 | 598 | 0.050 |
Why?
|
| Pyridones | 2 | 2016 | 711 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2010 | 2038 | 0.040 |
Why?
|
| Exophthalmos | 1 | 2000 | 97 | 0.040 |
Why?
|
| Epidermolysis Bullosa Dystrophica | 1 | 1999 | 26 | 0.040 |
Why?
|
| Ovalbumin | 3 | 2009 | 719 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2004 | 1851 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2014 | 767 | 0.040 |
Why?
|
| HLA Antigens | 3 | 2016 | 1382 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 17446 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 1985 | 1031 | 0.040 |
Why?
|
| Mucins | 1 | 2022 | 564 | 0.040 |
Why?
|
| Radiation Injuries, Experimental | 2 | 2011 | 91 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2009 | 1880 | 0.040 |
Why?
|
| Gestational Age | 1 | 2008 | 3493 | 0.040 |
Why?
|
| Hot Temperature | 2 | 1995 | 1356 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 8861 | 0.040 |
Why?
|
| Contrast Media | 3 | 2011 | 5300 | 0.040 |
Why?
|
| Lymphotoxin-alpha | 1 | 2018 | 98 | 0.040 |
Why?
|
| Kinetics | 3 | 2004 | 6476 | 0.040 |
Why?
|
| Cromolyn Sodium | 1 | 1999 | 87 | 0.040 |
Why?
|
| Necrosis | 5 | 1986 | 1643 | 0.040 |
Why?
|
| Autophagy | 2 | 2018 | 1297 | 0.040 |
Why?
|
| Cisplatin | 1 | 2004 | 1662 | 0.040 |
Why?
|
| Fucosyltransferases | 1 | 2018 | 119 | 0.040 |
Why?
|
| Antirheumatic Agents | 1 | 2008 | 1338 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2021 | 2938 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2022 | 1264 | 0.040 |
Why?
|
| Enzyme Stability | 1 | 2018 | 210 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2018 | 206 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 1 | 2012 | 2736 | 0.040 |
Why?
|
| Administration, Cutaneous | 2 | 2017 | 711 | 0.040 |
Why?
|
| Ecosystem | 1 | 2022 | 474 | 0.040 |
Why?
|
| Ear | 1 | 1998 | 173 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2019 | 552 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2002 | 1880 | 0.040 |
Why?
|
| Medical Records | 1 | 2003 | 1413 | 0.040 |
Why?
|
| Treatment Outcome | 7 | 2020 | 63107 | 0.040 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1997 | 64 | 0.040 |
Why?
|
| Adolescent | 8 | 2016 | 85779 | 0.040 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 1998 | 126 | 0.040 |
Why?
|
| Risk Factors | 3 | 2020 | 72296 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 13104 | 0.040 |
Why?
|
| Thymus Gland | 4 | 2005 | 1267 | 0.040 |
Why?
|
| Cytomegalovirus Infections | 2 | 1993 | 820 | 0.040 |
Why?
|
| 4-1BB Ligand | 1 | 2017 | 29 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 1340 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2018 | 10943 | 0.040 |
Why?
|
| Dogs | 2 | 2005 | 3912 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 1143 | 0.040 |
Why?
|
| Base Sequence | 4 | 2016 | 12797 | 0.040 |
Why?
|
| Cyclosporine | 1 | 2000 | 788 | 0.040 |
Why?
|
| Time Factors | 9 | 2014 | 40075 | 0.040 |
Why?
|
| Diffusion | 1 | 1999 | 832 | 0.040 |
Why?
|
| Lichen Planus, Oral | 1 | 2017 | 56 | 0.040 |
Why?
|
| Capsaicin | 1 | 1998 | 232 | 0.040 |
Why?
|
| Cilastatin | 1 | 2016 | 11 | 0.040 |
Why?
|
| Imipenem | 1 | 2016 | 38 | 0.040 |
Why?
|
| Piperacillin | 1 | 2016 | 41 | 0.040 |
Why?
|
| Lip | 1 | 2018 | 195 | 0.040 |
Why?
|
| Clathrin | 1 | 1998 | 267 | 0.030 |
Why?
|
| Pancreas | 1 | 2023 | 1687 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 1998 | 477 | 0.030 |
Why?
|
| Hydroxy Acids | 1 | 1996 | 18 | 0.030 |
Why?
|
| Histiocytes | 2 | 1987 | 103 | 0.030 |
Why?
|
| Transplantation, Isogeneic | 2 | 1986 | 257 | 0.030 |
Why?
|
| Penicillanic Acid | 1 | 2016 | 45 | 0.030 |
Why?
|
| Cats | 1 | 1997 | 1000 | 0.030 |
Why?
|
| Rabbits | 2 | 2005 | 4894 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 2076 | 0.030 |
Why?
|
| Bone Marrow Cells | 2 | 2007 | 2513 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 2013 | 518 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2004 | 3480 | 0.030 |
Why?
|
| Pityriasis | 1 | 2015 | 10 | 0.030 |
Why?
|
| Coagulants | 1 | 1996 | 49 | 0.030 |
Why?
|
| Pigmentation | 2 | 1987 | 148 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2003 | 1900 | 0.030 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2016 | 107 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2018 | 21748 | 0.030 |
Why?
|
| Membrane Proteins | 3 | 2014 | 7882 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 1998 | 915 | 0.030 |
Why?
|
| Haptens | 2 | 2003 | 166 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 2 | 2009 | 159 | 0.030 |
Why?
|
| Receptor, EphA3 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Genes, myb | 1 | 2014 | 18 | 0.030 |
Why?
|
| Cathepsin G | 1 | 1995 | 32 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 39052 | 0.030 |
Why?
|
| Erythema | 2 | 2014 | 257 | 0.030 |
Why?
|
| Mitotic Index | 1 | 2015 | 172 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 627 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1999 | 1572 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2014 | 72 | 0.030 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2014 | 44 | 0.030 |
Why?
|
| Keratosis, Actinic | 1 | 2015 | 74 | 0.030 |
Why?
|
| Reference Values | 2 | 1993 | 4982 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1997 | 433 | 0.030 |
Why?
|
| Purpura | 2 | 1987 | 122 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2024 | 2110 | 0.030 |
Why?
|
| Antibodies | 3 | 1996 | 2460 | 0.030 |
Why?
|
| Antigens, CD19 | 1 | 2017 | 380 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2018 | 1802 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2014 | 139 | 0.030 |
Why?
|
| Cornea | 1 | 2022 | 1524 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2023 | 8319 | 0.030 |
Why?
|
| Pigmentation Disorders | 3 | 1990 | 101 | 0.030 |
Why?
|
| Colitis | 2 | 2014 | 1170 | 0.030 |
Why?
|
| Sweat Gland Diseases | 2 | 1984 | 11 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 187 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 683 | 0.030 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2016 | 1596 | 0.030 |
Why?
|
| Radionuclide Imaging | 2 | 2011 | 2031 | 0.030 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2015 | 151 | 0.030 |
Why?
|
| Molecular Sequence Data | 5 | 2014 | 18111 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 906 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Color | 2 | 2005 | 233 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 1997 | 733 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 6364 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 1996 | 435 | 0.030 |
Why?
|
| Ischemia | 1 | 2022 | 1907 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2015 | 15297 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 862 | 0.030 |
Why?
|
| Natural Language Processing | 1 | 2021 | 1041 | 0.030 |
Why?
|
| Molecular Weight | 4 | 1995 | 2255 | 0.030 |
Why?
|
| Cicatrix | 1 | 2019 | 764 | 0.030 |
Why?
|
| Observer Variation | 1 | 1999 | 2593 | 0.030 |
Why?
|
| Fibronectins | 2 | 1993 | 726 | 0.030 |
Why?
|
| Immune System | 2 | 2008 | 806 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 1998 | 1152 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2014 | 343 | 0.030 |
Why?
|
| Bone Marrow | 3 | 2003 | 2948 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 8642 | 0.030 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2012 | 94 | 0.030 |
Why?
|
| Exocytosis | 1 | 2014 | 354 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3921 | 0.030 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2007 | 3143 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2017 | 1184 | 0.030 |
Why?
|
| Macaca mulatta | 3 | 1987 | 2377 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 2504 | 0.030 |
Why?
|
| Cytomegalovirus | 2 | 1993 | 733 | 0.030 |
Why?
|
| Duffy Blood-Group System | 1 | 2012 | 58 | 0.030 |
Why?
|
| Microvilli | 1 | 1992 | 241 | 0.030 |
Why?
|
| Pregnancy | 1 | 2014 | 29144 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2014 | 563 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 2751 | 0.030 |
Why?
|
| Interleukin-21 Receptor alpha Subunit | 1 | 2011 | 18 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 1998 | 1970 | 0.030 |
Why?
|
| Glycogen | 1 | 1992 | 259 | 0.030 |
Why?
|
| Vaccines, Attenuated | 1 | 1993 | 342 | 0.030 |
Why?
|
| Point Mutation | 1 | 1997 | 1624 | 0.030 |
Why?
|
| Hepatitis C, Chronic | 1 | 2020 | 1031 | 0.020 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 2011 | 66 | 0.020 |
Why?
|
| Rats | 3 | 2014 | 24252 | 0.020 |
Why?
|
| Reoperation | 1 | 2021 | 4201 | 0.020 |
Why?
|
| Neuroimmunomodulation | 1 | 1993 | 157 | 0.020 |
Why?
|
| Rosaniline Dyes | 1 | 2011 | 51 | 0.020 |
Why?
|
| Platelet Factor 4 | 1 | 1991 | 129 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 769 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 19905 | 0.020 |
Why?
|
| Anaplasia | 1 | 1990 | 16 | 0.020 |
Why?
|
| Vacuum | 1 | 2011 | 65 | 0.020 |
Why?
|
| Receptors, Interleukin | 1 | 2012 | 245 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2014 | 690 | 0.020 |
Why?
|
| Air Pressure | 1 | 2011 | 75 | 0.020 |
Why?
|
| HLA-A2 Antigen | 1 | 2011 | 213 | 0.020 |
Why?
|
| Metformin | 1 | 2018 | 836 | 0.020 |
Why?
|
| Betamethasone | 1 | 1991 | 45 | 0.020 |
Why?
|
| Occlusive Dressings | 1 | 2011 | 50 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2013 | 335 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2014 | 903 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1991 | 554 | 0.020 |
Why?
|
| Zebrafish | 1 | 2022 | 2996 | 0.020 |
Why?
|
| Differential Threshold | 2 | 1987 | 80 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2016 | 1958 | 0.020 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2010 | 123 | 0.020 |
Why?
|
| Antigenic Variation | 1 | 2011 | 125 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2015 | 1794 | 0.020 |
Why?
|
| Viscera | 1 | 1991 | 139 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 2949 | 0.020 |
Why?
|
| Parotid Neoplasms | 1 | 2012 | 155 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 453 | 0.020 |
Why?
|
| Dendrites | 2 | 1985 | 485 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2011 | 258 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2016 | 1355 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 890 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2011 | 791 | 0.020 |
Why?
|
| Facial Hemiatrophy | 1 | 1990 | 22 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 689 | 0.020 |
Why?
|
| Remission, Spontaneous | 1 | 1990 | 382 | 0.020 |
Why?
|
| Acetylglucosamine | 1 | 2011 | 191 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2016 | 2618 | 0.020 |
Why?
|
| Feces | 1 | 2016 | 1401 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1989 | 76 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 2008 | 2216 | 0.020 |
Why?
|
| Endothelial Cells | 2 | 2016 | 3486 | 0.020 |
Why?
|
| RNA | 2 | 2016 | 2749 | 0.020 |
Why?
|
| Neurofibroma | 1 | 1990 | 106 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2010 | 386 | 0.020 |
Why?
|
| Biodegradation, Environmental | 1 | 1990 | 219 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 1995 | 1284 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 1993 | 687 | 0.020 |
Why?
|
| Videotape Recording | 1 | 2011 | 352 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2018 | 1373 | 0.020 |
Why?
|
| Lysosomes | 1 | 2014 | 893 | 0.020 |
Why?
|
| Immune Sera | 1 | 1989 | 641 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1993 | 850 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2014 | 861 | 0.020 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2009 | 130 | 0.020 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2015 | 643 | 0.020 |
Why?
|
| Pedigree | 1 | 1997 | 4642 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2014 | 789 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2011 | 644 | 0.020 |
Why?
|
| Virus Replication | 1 | 2017 | 2535 | 0.020 |
Why?
|
| Elbow | 1 | 2009 | 138 | 0.020 |
Why?
|
| Perforin | 1 | 2009 | 168 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2014 | 1758 | 0.020 |
Why?
|
| Phylogeny | 1 | 2016 | 2804 | 0.020 |
Why?
|
| Human papillomavirus 16 | 1 | 2010 | 262 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2000 | 2119 | 0.020 |
Why?
|
| gp100 Melanoma Antigen | 1 | 2008 | 39 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 1993 | 1035 | 0.020 |
Why?
|
| Photosensitivity Disorders | 1 | 1988 | 78 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 972 | 0.020 |
Why?
|
| Mitosis | 2 | 1985 | 1208 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2011 | 566 | 0.020 |
Why?
|
| Lymph Node Excision | 2 | 2005 | 1262 | 0.020 |
Why?
|
| Boston | 1 | 2021 | 9312 | 0.020 |
Why?
|
| Clobetasol | 1 | 2008 | 34 | 0.020 |
Why?
|
| Atrophy | 2 | 1991 | 1584 | 0.020 |
Why?
|
| Cytological Techniques | 1 | 1990 | 219 | 0.020 |
Why?
|
| Polymyxin B | 1 | 1987 | 46 | 0.020 |
Why?
|
| Colon | 1 | 2016 | 1772 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 2012 | 0.020 |
Why?
|
| Granzymes | 1 | 2009 | 271 | 0.020 |
Why?
|
| Peanut Agglutinin | 1 | 1987 | 19 | 0.020 |
Why?
|
| Research | 1 | 1996 | 1999 | 0.020 |
Why?
|
| Selectins | 1 | 2008 | 102 | 0.020 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2008 | 143 | 0.020 |
Why?
|
| Cricetinae | 2 | 1999 | 2475 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 3873 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2016 | 2967 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 429 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2214 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 1987 | 248 | 0.020 |
Why?
|
| Models, Animal | 2 | 2005 | 2173 | 0.020 |
Why?
|
| Temperature | 1 | 2014 | 2204 | 0.020 |
Why?
|
| Viral Vaccines | 1 | 1993 | 636 | 0.020 |
Why?
|
| Panic Disorder | 1 | 2010 | 616 | 0.020 |
Why?
|
| Syndrome | 1 | 1993 | 3252 | 0.020 |
Why?
|
| Forearm | 1 | 2009 | 409 | 0.020 |
Why?
|
| Doxycycline | 1 | 1988 | 326 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2018 | 1905 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 20130 | 0.020 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2006 | 33 | 0.020 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2012 | 871 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1660 | 0.020 |
Why?
|
| Amino Acid Sequence | 4 | 2004 | 13814 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2008 | 534 | 0.020 |
Why?
|
| Prochlorperazine | 1 | 1986 | 17 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2021 | 40559 | 0.020 |
Why?
|
| Microvessels | 1 | 2011 | 544 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 1986 | 235 | 0.020 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2006 | 96 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2006 | 162 | 0.020 |
Why?
|
| Receptors, CCR4 | 1 | 2006 | 81 | 0.020 |
Why?
|
| Urticaria | 1 | 1987 | 150 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 1988 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6366 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4933 | 0.020 |
Why?
|
| Apolipoproteins D | 1 | 1985 | 14 | 0.020 |
Why?
|
| Tenascin | 2 | 1997 | 59 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 15078 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 2182 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 595 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2006 | 184 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 2890 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 1990 | 1179 | 0.020 |
Why?
|
| Morphogenesis | 1 | 1989 | 751 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 2418 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2011 | 4042 | 0.020 |
Why?
|
| Stomatitis | 1 | 1987 | 269 | 0.020 |
Why?
|
| Vaccination | 1 | 2017 | 3279 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1987 | 623 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2017 | 10252 | 0.020 |
Why?
|
| Haplorhini | 1 | 2005 | 552 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 1986 | 1162 | 0.020 |
Why?
|
| Receptors, CCR2 | 1 | 2005 | 212 | 0.020 |
Why?
|
| Conjunctival Neoplasms | 1 | 1985 | 79 | 0.020 |
Why?
|
| Pancytopenia | 1 | 2005 | 104 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2013 | 1271 | 0.020 |
Why?
|
| Dermatitis Herpetiformis | 1 | 1984 | 26 | 0.020 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2004 | 67 | 0.020 |
Why?
|
| Transplants | 1 | 2006 | 209 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 1985 | 315 | 0.010 |
Why?
|
| DNA | 1 | 2018 | 7294 | 0.010 |
Why?
|
| Vaccines | 1 | 1993 | 823 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4253 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 2004 | 112 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2916 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1986 | 608 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1987 | 772 | 0.010 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2004 | 87 | 0.010 |
Why?
|
| Histones | 1 | 2014 | 2598 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2005 | 667 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4208 | 0.010 |
Why?
|
| Anaphylaxis | 2 | 1995 | 746 | 0.010 |
Why?
|
| Haplotypes | 2 | 2003 | 2779 | 0.010 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2004 | 105 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 4666 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2015 | 2267 | 0.010 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2009 | 570 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2005 | 963 | 0.010 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 1984 | 85 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1983 | 237 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 6896 | 0.010 |
Why?
|
| Cautery | 1 | 1983 | 72 | 0.010 |
Why?
|
| Intestine, Large | 1 | 2002 | 71 | 0.010 |
Why?
|
| Cattle | 1 | 1989 | 3922 | 0.010 |
Why?
|
| Viral Load | 1 | 2012 | 3300 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2014 | 15520 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 2003 | 476 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2009 | 7721 | 0.010 |
Why?
|
| Vulvar Neoplasms | 1 | 1985 | 272 | 0.010 |
Why?
|
| Child, Preschool | 5 | 2000 | 41005 | 0.010 |
Why?
|
| Cytarabine | 1 | 1984 | 692 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2009 | 1211 | 0.010 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2010 | 944 | 0.010 |
Why?
|
| Burns | 1 | 2014 | 1815 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 2002 | 246 | 0.010 |
Why?
|
| 3,3'-Diaminobenzidine | 1 | 1981 | 5 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 2005 | 490 | 0.010 |
Why?
|
| Injections | 1 | 2005 | 840 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1987 | 1686 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1985 | 695 | 0.010 |
Why?
|
| Creatinine | 1 | 1987 | 1919 | 0.010 |
Why?
|
| Electron Probe Microanalysis | 1 | 1981 | 33 | 0.010 |
Why?
|
| Allergens | 1 | 2009 | 1320 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1983 | 876 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2015 | 3112 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2008 | 3130 | 0.010 |
Why?
|
| Testis | 1 | 2005 | 804 | 0.010 |
Why?
|
| Intestinal Mucosa | 2 | 2005 | 3037 | 0.010 |
Why?
|
| Tetracyclines | 1 | 1981 | 60 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1888 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1987 | 2242 | 0.010 |
Why?
|
| Xeromammography | 1 | 1980 | 21 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 1000 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1983 | 517 | 0.010 |
Why?
|
| Bronchi | 2 | 1995 | 840 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 2645 | 0.010 |
Why?
|
| Nuclear Envelope | 1 | 1982 | 172 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2004 | 675 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8385 | 0.010 |
Why?
|
| Keratosis | 1 | 1980 | 81 | 0.010 |
Why?
|
| Minocycline | 1 | 1981 | 163 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2011 | 2727 | 0.010 |
Why?
|
| Folate Receptors, GPI-Anchored | 1 | 1999 | 23 | 0.010 |
Why?
|
| Alcoholism | 1 | 2010 | 1906 | 0.010 |
Why?
|
| Computers | 1 | 1983 | 612 | 0.010 |
Why?
|
| Genomics | 1 | 2016 | 5717 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 1547 | 0.010 |
Why?
|
| Lymphadenitis | 1 | 1980 | 98 | 0.010 |
Why?
|
| Adenoma | 1 | 1990 | 2174 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2010 | 3024 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2004 | 2256 | 0.010 |
Why?
|
| Oxygen | 1 | 2011 | 4189 | 0.010 |
Why?
|
| Abdomen | 1 | 2005 | 1118 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5867 | 0.010 |
Why?
|
| Gastrointestinal Tract | 1 | 2005 | 814 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2000 | 251 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 2004 | 452 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2008 | 3203 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2008 | 1790 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2014 | 3751 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2004 | 1366 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2004 | 1115 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 2003 | 1041 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7282 | 0.010 |
Why?
|
| Desmoglein 3 | 1 | 1997 | 11 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 1701 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2011 | 5984 | 0.010 |
Why?
|
| Integrin alphaV | 1 | 1997 | 55 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 2751 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1987 | 2455 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1987 | 2282 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1995 | 1801 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 1984 | 3524 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1998 | 323 | 0.010 |
Why?
|
| Contractile Proteins | 1 | 1998 | 246 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2002 | 1157 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2018 | 53290 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 12952 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 2004 | 1599 | 0.010 |
Why?
|
| Prostate | 1 | 2005 | 1775 | 0.010 |
Why?
|
| CHO Cells | 1 | 1999 | 1409 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 1996 | 223 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1987 | 2148 | 0.010 |
Why?
|
| Endoplasmic Reticulum, Rough | 1 | 1996 | 21 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6234 | 0.010 |
Why?
|
| Laser Therapy | 1 | 1983 | 1072 | 0.010 |
Why?
|
| Neurons | 1 | 1995 | 9340 | 0.010 |
Why?
|
| Intestines | 1 | 2005 | 1924 | 0.010 |
Why?
|
| Proteins | 1 | 1991 | 6100 | 0.010 |
Why?
|
| Connective Tissue Cells | 1 | 1995 | 55 | 0.010 |
Why?
|
| Mitochondria | 1 | 1988 | 3514 | 0.010 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1975 | 45 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1995 | 156 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1995 | 109 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1995 | 518 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1998 | 2050 | 0.010 |
Why?
|
| Photochemistry | 1 | 1995 | 238 | 0.010 |
Why?
|
| Intercellular Junctions | 1 | 1975 | 203 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 3773 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2015 | 23336 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 2839 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 12262 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2000 | 1782 | 0.010 |
Why?
|
| Antilymphocyte Serum | 1 | 1975 | 492 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2000 | 1487 | 0.010 |
Why?
|
| Injections, Intradermal | 1 | 1993 | 117 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1980 | 20824 | 0.010 |
Why?
|
| Autoantigens | 1 | 1997 | 892 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1995 | 1095 | 0.010 |
Why?
|
| Peptides | 1 | 1985 | 4410 | 0.010 |
Why?
|
| Homozygote | 1 | 1997 | 1787 | 0.010 |
Why?
|
| Infant | 3 | 2000 | 35134 | 0.010 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 1993 | 266 | 0.010 |
Why?
|
| Autoantibodies | 2 | 1993 | 2036 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1975 | 675 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 4320 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1996 | 1375 | 0.010 |
Why?
|
| Indomethacin | 1 | 1991 | 332 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1996 | 1213 | 0.010 |
Why?
|
| Skin Tests | 1 | 1993 | 613 | 0.010 |
Why?
|
| Adrenal Cortex | 1 | 1991 | 140 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1991 | 829 | 0.010 |
Why?
|
| Enophthalmos | 1 | 1990 | 34 | 0.010 |
Why?
|
| United States | 2 | 2013 | 69872 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1982 | 2530 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 4740 | 0.010 |
Why?
|
| Species Specificity | 1 | 1993 | 2478 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1988 | 115 | 0.010 |
Why?
|
| Facial Bones | 1 | 1990 | 201 | 0.010 |
Why?
|
| Trigeminal Nerve | 1 | 1990 | 249 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15535 | 0.010 |
Why?
|
| Obesity | 1 | 2010 | 12746 | 0.000 |
Why?
|
| Brain | 1 | 1995 | 26388 | 0.000 |
Why?
|
| Hydroxyproline | 1 | 1987 | 116 | 0.000 |
Why?
|
| Deltaretrovirus Infections | 1 | 1986 | 26 | 0.000 |
Why?
|
| Child | 3 | 2000 | 77709 | 0.000 |
Why?
|
| Infusion Pumps | 1 | 1987 | 163 | 0.000 |
Why?
|
| Protein Binding | 1 | 1998 | 9384 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 2000 | 12025 | 0.000 |
Why?
|
| Spectrum Analysis | 1 | 1987 | 454 | 0.000 |
Why?
|
| Physical Examination | 1 | 1990 | 1237 | 0.000 |
Why?
|
| HLA-C Antigens | 1 | 1983 | 147 | 0.000 |
Why?
|
| Telophase | 1 | 1982 | 7 | 0.000 |
Why?
|
| HLA-A Antigens | 1 | 1983 | 232 | 0.000 |
Why?
|
| Prophase | 1 | 1982 | 17 | 0.000 |
Why?
|
| Ethanolamines | 1 | 1983 | 158 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1983 | 919 | 0.000 |
Why?
|
| Metaphase | 1 | 1982 | 151 | 0.000 |
Why?
|
| Indicators and Reagents | 1 | 1983 | 462 | 0.000 |
Why?
|
| Anaphase | 1 | 1982 | 120 | 0.000 |
Why?
|
| Interphase | 1 | 1982 | 226 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1983 | 549 | 0.000 |
Why?
|
| HLA-B Antigens | 1 | 1983 | 354 | 0.000 |
Why?
|
| Triazines | 1 | 1983 | 315 | 0.000 |
Why?
|
| Ribs | 1 | 1982 | 252 | 0.000 |
Why?
|
| Eyelid Neoplasms | 1 | 1982 | 94 | 0.000 |
Why?
|
| Warts | 1 | 1980 | 68 | 0.000 |
Why?
|
| Immunoglobulin A | 1 | 1984 | 995 | 0.000 |
Why?
|
| Radiography | 1 | 1990 | 7023 | 0.000 |
Why?
|
| Mandible | 1 | 1982 | 740 | 0.000 |
Why?
|
| Extremities | 1 | 1982 | 866 | 0.000 |
Why?
|